Wacker Neuson SE / Key word(s): Change in Forecast/Half Year Results 03.08.2016 20:37 Disclosure of an inside information according to Article 17 MAR, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Wacker Neuson SE: Ad-hoc press release in line with Article 15 of the German Securities Trading Act (WpHG) Wacker Neuson Group revises its forecast (Munich, August 3, 2016) The Wacker Neuson Group has lowered its revenue and profit forecast for the current fiscal year in line with more subdued expectations for the second half of the year. Wacker Neuson Group revenue for the second quarter of 2016 amounted to EUR 381.4 million and thus almost matched the record figure reported for the previous year (Q2 2015: EUR 382.1 million). Profit before interest and tax (EBIT) remained almost unchanged from the previous year's level at EUR 33.4 million (Q2 2015: EUR 34.0 million). The EBIT margin was 8.8 percent (Q2 2015: 8.9 percent). In the first half of the year, Group revenue came to EUR 697.8 million (H1 2015: EUR 706.4 million) and was thus 1.2 percent lower than the previous year (H1 2015: EUR 706.4 million) - a development attributable to the weak first quarter of 2016. Due to the drop in Q1 earnings, EBIT for the first half-year decreased 23 percent relative to the previous year to reach EUR 50.7 million. The EBIT margin was 7.3 percent (H1 2015: EUR 65.7 million; 9.3 percent). However, preliminary figures for July show that the Wacker Neuson Group experienced a weak start to the second half of the year. High-risk markets such as Russia, South Africa, Turkey and, most recently, the UK are currently generating increasing levels of uncertainty in Europe. The European agricultural market was also showing no signs of long-term recovery at the start of the second half of the year. At the same time, market weaknesses in North America are proving to be more persistent than expected and many emerging markets are still not showing signs of recovery. The company therefore expects revenue and profit for the second half of the year to develop below previous expectations. In light of these developments, the Executive Board reduced its forecast for the year as a whole. It now expects revenue for fiscal 2016 to range between EUR 1,375 and EUR 1,425 million (previously: between EUR 1,400 and EUR 1,450 million) with an EBIT margin of between 6.5 and 7.5 percent (previously: between 7.0 and 8.0 percent). Explanation on KPIs applied are described in the annual report of Wacker Neuson Group 2015 on page 158 (Website: http://wackerneusongroup.com/en/ investor-relations/financial-reports-presentations/2015/) Additional information on Wacker Neuson SE shares: ISIN: DE000WACK012 WKN: WACK01 Admission: Regulated market / Prime Standard; Frankfurt Stock Exchange Company headquarters: Germany Your contact partner: Wacker Neuson SE Katrin Yvonne Neuffer Head of Corporate Communication / Investor Relations Preussenstrasse 41 80809 Munich, Germany Phone: +49-(0)89-35402-173 katrin.neuffer@wackerneuson.com www.wackerneusongroup.com 03.08.2016 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de --------------------------------------------------------------------------- Language: English Company: Wacker Neuson SE Preußenstr. 41 80809 München Germany Phone: +49 - (0)89 - 354 02 - 0 Fax: +49 - (0)89 - 354 02 - 390 E-mail: ir@wackerneuson.com Internet: www.wackerneusongroup.com ISIN: DE000WACK012 WKN: WACK01 Indices: SDAX Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-Adhoc: Wacker Neuson SE: Wacker Neuson Group revises
Top 10 Most Recent News Articles
Microtubule Defects Revealed: Impacts on Cancer Treatment
Peering into the Heart of Microtubules Ever squint at a tapestry, only to find a rogue thread ruining the pattern? Well, that’s somewhat what scientists at Kanazawa University have found with microtubules, those tiny rods in our cells that usually keep it all together. Using some pretty fancy tech called high-speed atomic force microscopy, these folks peered into the...
Continue Reading
Gillis Joins McGinnis Lochridge as COO Amid Firm's Milestone
An Experienced Executor at the Helm Now, here's a story that rings of continuity meeting change. McGinnis Lochridge, a staple of the Texas legal scene since 1927, has tapped Charles Gillis to take charge as their Chief Operating Officer. You'd think they're gearing up to celebrate a hundred years by shaking things up internally. Why not bring in someone seasoned, I say?...
Continue Reading
Low GWP Refrigerants: Potential $13B Market by 2031
Refrigerants: They're Hot in More Ways Than One Who would've thought refrigerants could be such a big deal? But here we are. The low global warming potential (GWP) refrigerants market is heating up, projected to jump from $8.17 billion in 2026 to a whopping $13.06 billion by 2031. That's a solid 9.8% CAGR if you're keeping score. The drivers? Well, we’ve got...
Continue Reading
Denver Arts Week: A Cultural Extravaganza Returns
Denver's got its art game on again, folks—a sprawling fiesta for the senses called Denver Arts Week is making its return from November 6 to 15. Pack your bags, grab a parka, or whatever you need to brace the Colorado chill, as this ain't just any regular art crawl—it's a full-blown celebration with nearly 300 events jam-packed across the city. If you blink, Denver...
Continue Reading
Expert Vet Advice: When Pet Surgery Is Necessary
Tough Calls: Knowing When Your Pet Needs Surgery Alright, when it comes to our furry companions, knowing when to opt for surgery ain't no walk in the park. It's a tricky balance, folks. Is that lump something to worry about? Will that limp heal on its own? HelloNation's recent piece dives into these questions, leveraging the expertise of Veterinarian Lorrie Riggs from...
Continue Reading
James Cahill's Centenary: Honoring a Chinese Art Pioneer
A Celebration of a Visionary in Chinese Art In the typically bustling city of Hangzhou, a quiet reverence fell at the China Academy of Art (CAA) on October 17–18, 2026. There, they marked the centenary of one of the titans of art history, James Francis Cahill. He was the kind of person who could walk into a room and change how you looked at the walls. His legacy...
Continue Reading
Littleton U-Pull-It Kicks off New Era with a Bang
A Fresh Chapter for Littleton U-Pull-It There's nothing quite like the thrill of a new beginning, especially when it promises to shake up the local business scene. Littleton U-Pull-It, under new ownership, seems to be gearing up for exactly that. They're setting the stage with a grand opening event on October 24. When old hands in the business world like me see moves like...
Continue Reading
Ford Foundation's New Strategy Tackles Global Democracy
New Directions in a Changing World Standing at a crossroads of geopolitical upheaval and global uncertainty, the Ford Foundation is shaking things up with a fresh playbook aimed squarely at bolstering democracy across the globe. On October 22, 2026, they rolled out a game plan that's all about reinforcing the backbone of democratic values, essential freedoms, and...
Continue Reading
Clarivate Taps Global Appetite for AI Research Tools
A Growing Global Thirst for AI-Enhanced Research It looks like the folks at Clarivate have struck a chord. Their Web of Science Research Intelligence platform is garnering attention across the globe, embraced by more than 100 institutions spanning 25 countries. When you craft something that taps into a core need, well, people will jump on it—and that's exactly what's...
Continue Reading
Direct Digital's Bold Exit: Delists from Nasdaq
Delisting Drama: Navigating Direct Digital's Market Move Looks like Direct Digital Holdings is getting caught up in the whirlwind of delisting and deregistering its Class A common stock from the Nasdaq. This move isn't just about hopping off a big exchange—it’s a whole new set of dance steps in the market. Timing and Mechanics of the Departure They’ve set their...
Continue ReadingTop 5 Most Recently Viewed Articles
Costco’s Earnings Anticipation Boosts Market Interest
Costco’s Earnings Anticipation Boosts Market Interest Costco Wholesale Corporation (NASDAQ: COST) is generating significant buzz as it heads into its fourth-quarter earnings report, which is set to unveil crucial financial insights. Analysts are eagerly awaiting the results, with many predicting strong performance metrics. What to Expect from the Upcoming Earnings...
Continue Reading
Clara Feldman's Leadership Role at Blank Rome Unveiled
Clara Feldman Joins Blank Rome's Luxury Brands Practice Blank Rome LLP is excited to welcome Clara Feldman as the chair of its newly established Luxury Brands practice in New York. This initiative brings together a talented team of attorneys dedicated to providing sophisticated legal expertise to high-end brands. Clara, with her extensive background, is set to enhance the...
Continue Reading
A Paradise Acquisition Corp. Separates Trading of Shares Soon
Overview of A Paradise Acquisition Corp. A Paradise Acquisition Corp. (NASDAQ: APADU) is a special purpose acquisition company (SPAC) designed primarily for merging with businesses. Its mission is to initiate mergers or other business combinations, specifically in the leisure and entertainment sectors. Upcoming Trading Changes Starting soon, holders of units sold during...
Continue Reading
Treatment.com AI Inc. Completes Successful Private Placement
Treatment.com AI Inc. Completes Successful Private Placement Recently, Treatment.com AI Inc. (CSE: TRUE; OTC: TREIF; FFA: 939) shared exciting news about a significant milestone in its funding journey. The company has successfully closed an over-subscribed non-brokered private placement of special warrants and units, totaling an impressive $1,954,074. This move comes on...
Continue Reading
Atossa Therapeutics Announces Promising Results from Endoxifen Study
Atossa Therapeutics Unveils Positive Results from KARISMA-Endoxifen Trial (Z)-Endoxifen has been shown to significantly reduce mammographic breast density, potentially leading to groundbreaking strategies for cancer prevention. Atossa Therapeutics, Inc. (Nasdaq: ATOS), a biopharmaceutical company operating in the clinical stage with a dedication to developing innovative...
Continue Reading